NCT04380103 2020-05-08A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal CancerChineseAMSPhase 1/2 Unknown106 enrolled
NCT01542294 2016-06-14SOX as Adjuvant Chemotherapy for Resectable Gastric CancerChineseAMSPhase 1/2 Unknown71 enrolled